Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

European Respiratory Journal

Volumn 17, Issue 3, 2001, Pages 337-342

  Schols, A M W J ^a   Wesseling, G ^a   Kester, A D M ^a   de Vries, G ^a   Mostert, R ^a   Slangen, J ^a   Wouters, E F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive; Corticosteroids; Pulmonary disease; Survival; Systemic administration

Indexed keywords

BETAMETHASONE; GLUCOCORTICOID; PREDNISONE; SALBUTAMOL;

ADULT; AGE; AGED; ARTERIAL GAS; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG INTERACTION; DRUG UTILIZATION; FEMALE; FOLLOW UP; GENDER; GLUCOSE INTOLERANCE; HAZARD; HUMAN; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYOPATHY; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REHABILITATION CENTER; RETROSPECTIVE STUDY; RISK; SMOKING; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ADMINISTRATION, ORAL; AGED; BETAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISOLONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034955633     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17303370     Document Type: Article

References (24)

1. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis
2. Emerging role of corticosteroids in chronic obstructive pulmonary disease
3. Pharmacologic therapy of obstructive airway disease
4. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
5. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
6. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
7. Adverse effects of corticosteroid therapy for COPD. A critical review
8. Standardized lung function testing
9. Multicenter randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
10. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease
11. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
12. Outcomes following acute exacerbations of severe chronic obstructive lung disease
13. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
14. Use of drugs for CNSLD (asthma and COPD) in Dutch residential homes and nursing homes
15. A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1500 microg/day in patients with adult onset chronic obstructive airways disease
16. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease
17. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
18. Peripheral muscle weakness contributes to exercise limitation in COPD
19. Peripheral muscle weakness is associated with reduced survival in COPD
20. Respiratory and skeletal muscle function in steroid-dependent bronchial asthma
21. Contractile properties and histochemical characteristics of the rat diaphragm after prolonged triamcinolone treatment and nutritional deprivation
22. Risk of infectious complications in patients taking glucocorticosteroids
23. Beclomethasone inhalation decreases serum osteocalcin concentrations
24. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease